Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy
- 8 January 2003
- journal article
- clinical trial
- Published by Elsevier BV in Epilepsy Research
- Vol. 53 (1-2), 57-64
- https://doi.org/10.1016/s0920-1211(02)00247-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Aggravation of partial seizures by antiepileptic drugsNeurology, 2002
- Long-term continuation of levetiracetam in patients with refractory epilepsyNeurology, 2001
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Levetiracetam for partial seizuresNeurology, 2000
- A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsySeizure, 2000
- Difficulties in extrapolating from clinical trial data to clinical practice: The case of antiepileptic drugsNeurology, 1997